Goldman Sachs Group Inc Capricor Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 71,971 shares of CAPR stock, worth $578,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,971
Previous 411,141 82.49%
Holding current value
$578,646
Previous $3.9 Million 81.7%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$6.34 - $14.23 $2.15 Million - $4.83 Million
-339,170 Reduced 82.49%
71,971 $714,000
Q1 2025

May 09, 2025
BUY
$9.49 - $16.11 $1.1 Million - $1.87 Million
116,373 Added 39.48%
411,141 $3.9 Million
Q4 2024

Feb 11, 2025
BUY
$12.9 - $21.99 $2.79 Million - $4.76 Million
216,504 Added 276.63%
294,768 $4.08 Million
Q3 2024

Nov 14, 2024
SELL
$3.56 - $15.21 $15,777 - $67,410
-4,432 Reduced 5.36%
78,264 $1.19 Million
Q2 2024

Aug 13, 2024
SELL
$4.63 - $7.09 $604,089 - $925,053
-130,473 Reduced 61.21%
82,696 $394,000
Q1 2024

May 15, 2024
BUY
$3.61 - $6.88 $714,523 - $1.36 Million
197,929 Added 1298.75%
213,169 $1.45 Million
Q4 2023

Feb 13, 2024
SELL
$2.71 - $5.08 $25,227 - $47,289
-9,309 Reduced 37.92%
15,240 $74,000
Q3 2023

May 14, 2024
BUY
$3.42 - $7.85 $31,836 - $73,075
9,309 Added 61.08%
24,549 $83,000
Q2 2023

May 14, 2024
SELL
$3.76 - $5.05 $282 - $378
-75 Reduced 0.3%
24,549 $117,000
Q2 2023

Aug 14, 2023
SELL
$3.76 - $5.05 $282 - $378
-75 Reduced 0.3%
24,549 $117,000
Q1 2023

May 14, 2024
BUY
$3.78 - $5.03 $113 - $150
30 Added 0.12%
24,624 $103,000
Q1 2023

May 11, 2023
BUY
$3.78 - $5.03 $113 - $150
30 Added 0.12%
24,624 $103,000
Q4 2022

May 14, 2024
SELL
$3.36 - $6.55 $1,243 - $2,423
-370 Reduced 1.48%
24,594 $94,000
Q4 2022

Feb 13, 2023
SELL
$3.36 - $6.55 $1,243 - $2,423
-370 Reduced 1.48%
24,594 $94,000
Q3 2022

May 14, 2024
BUY
$3.61 - $6.08 $54 - $91
15 Added 0.06%
24,964 $150,000
Q3 2022

Nov 10, 2022
BUY
$3.61 - $6.08 $54 - $91
15 Added 0.06%
24,964 $0
Q2 2022

May 14, 2024
BUY
$2.89 - $4.51 $28,059 - $43,787
9,709 Added 63.71%
24,949 $87,000
Q2 2022

Aug 15, 2022
SELL
$2.89 - $4.51 $49,965 - $77,973
-17,289 Reduced 40.93%
24,949 $87,000
Q1 2022

May 16, 2022
BUY
$2.83 - $5.68 $33,453 - $67,143
11,821 Added 38.86%
42,238 $145,000
Q4 2021

Feb 14, 2022
BUY
$2.89 - $4.16 $23,926 - $34,440
8,279 Added 37.4%
30,417 $89,000
Q3 2021

Nov 10, 2021
BUY
$3.8 - $5.23 $84,124 - $115,781
22,138 New
22,138 $89,000

Others Institutions Holding CAPR

# of Institutions
139
Shares Held
12.3M
Call Options Held
4.98M
Put Options Held
5.48M
View Full List

About CAPRICOR THERAPEUTICS, INC.

CAPR Quotes by TradingView
  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $196M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email